AbCellera Biologics (ABCL) vs Veradermics (MANE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Veradermics is the larger company by market cap ($4.64 billion vs $4.16 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ABCL | MANE |
|---|---|---|
| Share price | $12.83 | $110.95 |
| Market cap | $4.16B | $4.64B |
| 1-day change | -2.43% | +1.83% |
| YTD return | +275.15% | — |
| 1-year return | +122.36% | — |
| 5-year return | -17.39% | — |
| EPS (TTM) | $-0.53 | $-4.32 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $75.13M | — |
| Revenue growth (YoY) | +160.56% | — |
| Net income (latest FY) | $-146.41M | $-70.00M |
| Operating margin | -288.98% | — |
| Net margin | -194.88% | — |
| 52-week high | $15.02 | $131.24 |
| 52-week low | $2.75 | $32.00 |
| Distance from 52-week high | -14.55% | -15.46% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +30.16% | +47.36% |
| Average volume | 6.74M | 730.99K |
| Shares outstanding | 324.05M | 41.78M |
| Employees | 562 | 37 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About AbCellera Biologics
ABCL stock →AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 562 employees
About Veradermics
MANE stock →Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children.
Health Care · Biotechnology: Pharmaceutical Preparations · 37 employees
ABCL vs MANE FAQ
Which is bigger, AbCellera Biologics or Veradermics?
Veradermics (MANE) is larger, with a market capitalization of $4.64B compared with $4.16B for AbCellera Biologics (ABCL).
Are AbCellera Biologics and Veradermics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.